Received Aug 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 2 | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | — | — |
No additional AE; second dose of VARIVAX on 05AUG2025; a first dose of MMR-II on 30JUN2025; This spontaneous report was received from a medical assistant and refers to a Child patient (currently 4-year-old, age at onset was not provided) of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 30-Jun-2025, the patient was vaccinated with the first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (Inappropriate age at vaccine administration) and sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not reported); with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) and sterile diluent (MERCK STERILE DILUENT). On 05-Aug-2025, the patient was vaccinated with the second dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) and sterile diluent (MERCK STERILE DILUENT); with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (Inappropriate schedule of vaccine administered) and sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not reported). All were for prophylaxis. No additional event was reported (no adverse event). Lot # is being requested and will be submitted if received.
Sterile Diluent